1. Catalogs
  2. HemoCue
  3. HemoCue ® Glucose 201 + System

HemoCue ® Glucose 201 + System

HemoCue ® Glucose 201 + System

HemoCue ® Glucose 201 + System

Product catalog summary
Overview
The HemoCue® Glucose 201+ System is designed for point-of-care testing, providing lab-equivalent results for diabetes screening, monitoring, and diagnosis. It ensures precise glycemic control and reduces the risk of missed hypoglycemia in newborns.

Key Features
  • Accuracy and Safety: Utilizes microcuvette technology to minimize infection risk and contamination. The system is factory calibrated, eliminating the need for recalibration.
  • Convenience: Handheld, battery-operated, and suitable for mobile settings.
  • Simple Operation: Involves three steps: filling the microcuvette, placing it into the analyzer, and viewing results.

Technical Specifications
  • Measurement Principle: Modified glucose dehydrogenase with photometric endpoint measurement.
  • Calibration: Factory calibrated, traceable to ID GC-MS method.
  • Sample Material: Capillary, venous, or arterial whole blood.
  • Measurement Range: Plasma equivalent values: 0–24.6 mmol/L (0–444 mg/dL); Whole blood values: 0–22.2 mmol/L (0–400 mg/dL).
  • Sample Volume: Less than 5 µL.
  • Dimensions and Weight: 160 × 85 × 43 mm, 350 g with batteries.
  • Temperature Range: Storage: 0–50 °C; Operating: 15–30 °C.
  • Power: AC Adapter or 4 AA batteries.
  • Interface: Includes printer and barcode scanner connectivity.
  • Quality Control: Built-in self-test and verification with liquid controls.

Performance
The system demonstrates high correlation with the ID GC-MS method, ensuring reliable and accurate glucose measurements.
See more

Catalog excerpts

HemoCue ® Glucose 201 + System-1

HemoCue® Glucose 201+ System Accurate Answers With Full Confidence The HemoCue® Glucose 201+ system puts labequivalent answers in health professionals’ hands when they’re needed most — at the point of care. Not only does the unique cuvette technology enable the highest accuracy in just three simple steps, but it reduces serious contamination risks. Accuracy Starts With Us Enables Right Decisions at the Point of Care Used for screening, monitoring and diagnosis of diabetes mellitus Precise monitoring for better glycemic control Reduced risk of missed hypoglycemia in newborns Reduces Margins of Error and Risks of Infection Microcuvette technology means no need to bring analyzer near patients, reducing the risk of spreading infection Individually wrapped microcuvettes to avoid contamination and maximize shelf-life No clinically significant lot-to-lot variation Fixed analyzer calibration, means no need to recalibrate Offers Convenience and Flexibility Handheld and battery-operated system ideal for mobile settings To learn more about HemoCue® Glucose 201+ System, please scan the QR-code with your smartphone or visit hemocue.com

 Open the catalog to page 1
HemoCue ® Glucose 201 + System-2

HemoCue® Glucose 201+ System ID GC-MS, singel mmol/L 0 Factory calibrated and traceable to the ID GC-MS method; needs no further calibration and no coding Sample Material Capillary, venous or arterial whole blood Measurement Range Plasma equivalent values: 0–24.6 mmol/L (0–444 mg/dL) Whole blood values: 0–22.2 mmol/L (0–400 mg/dL) Within one minute for normal glucose levels HemoCue Glucose 201 individual s (mmol/L) Modified glucose dehydrogenase in which the total amount of glucose is measured at the end point photometrically HemoCue Glucose 201 individuals (mg/dL) ID GC-MS, singel mg/dL Sample...

 Open the catalog to page 2

All HemoCue catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.